Enterprise Value Summary (Quarterly)
According to Vaxcyte's latest quarterly financial reports:
- The enterprise value (EV) is 9.74B, which includes the market capitalization, debt, and subtracts cash and cash equivalents. EV provides a more comprehensive measure of a company's total value.
- The market capitalization is 9.99B, which is calculated by multiplying the current share price by the total number of outstanding shares.
- The stock price is $81.86, with 122.85M shares outstanding.
- The company has 387.88M in cash and cash equivalents and 71.11M in total debt.
Enterprise Value (EV) Formula:
EV = Market Cap + Total Debt - Cash and Cash Equivalents
Enterprise value is often used instead of market cap because it provides a more accurate valuation of a company by including debt and subtracting cash, giving a fuller picture of the company's total value.
Enterprise Value
$9.74B
Market Cap
$10.06B
Total Debt
$71.11M
Cash and Equivalents
$387.88M
Historical Enterprise Value
Vaxcyte Historical Enterprise Values
The table below shows various enterprise value metrics for each quarter, with the latest data available for 2024-12-31.
| Date | Enterprise Value | EV Change (%) | Stock Price | Number of Shares | Market Cap | Cash & Equivalents | Total Debt |
|---|---|---|---|---|---|---|---|
| December 31, 2024 | $9.74B | -25.72% | $81.86 | 122.85M | $10.06B | $387.88M | $71.11M |
| September 30, 2024 | $13.11B | 53.74% | $114.27 | 123.69M | $14.13B | $1.05B | $27.96M |
| June 30, 2024 | $8.53B | 24.16% | $76.94 | 117.26M | $9.02B | $518.67M | $25.58M |
| March 31, 2024 | $6.87B | 13.15% | $66.73 | 111.69M | $7.45B | $611.51M | $27.42M |
| December 31, 2023 | $6.07B | 30.50% | $62.8 | 102.53M | $6.44B | $397.45M | $29.22M |
| September 30, 2023 | $4.65B | 6.18% | $50.98 | 101.67M | $5.18B | $545.13M | $13.81M |
| June 30, 2023 | $4.38B | 90.67% | $49.94 | 98.06M | $4.90B | $531.03M | $15.21M |
| March 31, 2023 | $2.30B | -22.68% | $37.48 | 86.21M | $3.23B | $949.85M | $16.59M |
| December 31, 2022 | $2.97B | 160.39% | $47.95 | 79.01M | $3.79B | $834.66M | $17.94M |
| September 30, 2022 | $1.14B | 3.15% | $24 | 61.99M | $1.49B | $366.20M | $19.78M |
| June 30, 2022 | $1.11B | -8.20% | $21.76 | 60.82M | $1.32B | $238.17M | $21.20M |
| March 31, 2022 | $1.21B | 0.10% | $24.15 | 57.33M | $1.38B | $201.74M | $22.41M |
| December 31, 2021 | $1.20B | -0.92% | $23.79 | 52.81M | $1.26B | $68.98M | $16.78M |
| September 30, 2021 | $1.22B | 20.48% | $25.41 | 52.19M | $1.33B | $112.04M | $1.17M |
| June 30, 2021 | $1.01B | 24.08% | $22.51 | 51.48M | $1.16B | $151.00M | $935.00K |
| March 31, 2021 | $812.90M | -16.02% | $19.75 | 51.17M | $1.01B | $198.94M | $1.13M |
| December 31, 2020 | $967.91M | 55.16% | $26.57 | 50.96M | $1.35B | $386.20M | $- |
| September 30, 2020 | $623.83M | -1788.17% | $49.38 | 20.67M | $1.02B | $397.05M | $- |
| June 30, 2020 | $-36.95M | -24.45% | $31.61 | 11.80M | $373.09M | $410.05M | $- |
| March 31, 2020 | $-48.91M | -208.88% | $26.15 | 4.05M | $105.88M | $154.79M | $- |
| December 31, 2019 | $44.92M | -55.46% | $26.15 | 3.97M | $103.74M | $58.98M | $161.00K |
| September 30, 2019 | $100.86M | 4.75% | $26.15 | 3.86M | $100.86M | $- | $- |
| June 30, 2019 | $96.28M | -40.60% | $26.15 | 3.68M | $96.28M | $- | $- |
| March 31, 2019 | $162.09M | - | $26.15 | 3.67M | $96.00M | $-66.09M | $- |
Related Metrics
Explore detailed financial metrics and analysis for PCVX.